Susanne Koeppen

4.0k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Susanne Koeppen is a scholar working on Neurology, Genetics and Oncology. According to data from OpenAlex, Susanne Koeppen has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Susanne Koeppen's work include Peripheral Neuropathies and Disorders (6 papers), Glioma Diagnosis and Treatment (6 papers) and Cancer Treatment and Pharmacology (6 papers). Susanne Koeppen is often cited by papers focused on Peripheral Neuropathies and Disorders (6 papers), Glioma Diagnosis and Treatment (6 papers) and Cancer Treatment and Pharmacology (6 papers). Susanne Koeppen collaborates with scholars based in Germany, United States and Switzerland. Susanne Koeppen's co-authors include Michael Weller, Wolfgang Wick, Guido Reifenberger, Andreas von Deimling, Michael Sabel, Ralf Ketter, Dirk Strumberg, M. E. Scheulen, Christian Hartmann and Florian Stockhammer and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Neurology.

In The Last Decade

Susanne Koeppen

28 papers receiving 1.6k citations

Hit Papers

NOA-04 Randomized Phase I... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Koeppen Germany 18 794 385 375 330 307 33 1.6k
N C Yue United States 11 867 1.1× 345 0.9× 707 1.9× 309 0.9× 229 0.7× 13 1.8k
J. Y. Delattre France 16 657 0.8× 375 1.0× 759 2.0× 311 0.9× 454 1.5× 46 1.7k
Steffen Albrecht Canada 23 535 0.7× 324 0.8× 320 0.9× 709 2.1× 163 0.5× 56 1.8k
Niklas Schäfer Germany 21 560 0.7× 287 0.7× 300 0.8× 213 0.6× 180 0.6× 78 1.2k
Glen Stevens United States 30 1.3k 1.7× 547 1.4× 1.1k 2.8× 506 1.5× 525 1.7× 100 2.6k
Chiara Villa France 25 579 0.7× 279 0.7× 219 0.6× 312 0.9× 113 0.4× 70 1.6k
Büğe Öz Türkiye 21 219 0.3× 244 0.6× 480 1.3× 255 0.8× 285 0.9× 122 1.6k
David Husband United Kingdom 23 530 0.7× 98 0.3× 484 1.3× 581 1.8× 467 1.5× 59 2.2k
J. G. Cairncross Canada 10 1.3k 1.7× 194 0.5× 652 1.7× 253 0.8× 213 0.7× 11 1.7k
Robert Laing United Kingdom 26 370 0.5× 148 0.4× 1.3k 3.5× 244 0.7× 367 1.2× 81 2.1k

Countries citing papers authored by Susanne Koeppen

Since Specialization
Citations

This map shows the geographic impact of Susanne Koeppen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Koeppen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Koeppen more than expected).

Fields of papers citing papers by Susanne Koeppen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Koeppen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Koeppen. The network helps show where Susanne Koeppen may publish in the future.

Co-authorship network of co-authors of Susanne Koeppen

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Koeppen. A scholar is included among the top collaborators of Susanne Koeppen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Koeppen. Susanne Koeppen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Raymond Y., Prashin Unadkat, Wenya Linda Bi, et al.. (2018). Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression. Neuro-Oncology. 21(2). 234–241. 22 indexed citations
3.
Wick, Wolfgang, Patrick Roth, Benedikt Wiestler, et al.. (2015). Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.. Journal of Clinical Oncology. 33(15_suppl). 2001–2001. 32 indexed citations
4.
Furtner, Julia, Veronika Schöpf, Katharina Seystahl, et al.. (2015). Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro-Oncology. 18(3). 401–407. 42 indexed citations
5.
Koeppen, Susanne. (2014). Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy. Oncology Research and Treatment. 37(9). 506–513. 31 indexed citations
6.
Pachman, Deirdre R., James C. Watson, Maryam B. Lustberg, et al.. (2014). Management options for established chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer. 22(8). 2281–2295. 37 indexed citations
7.
Wick, Wolfgang, Christoph Meisner, Bettina Hentschel, et al.. (2013). Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology. 81(17). 1515–1522. 173 indexed citations
8.
Wick, Wolfgang, Christian Hartmann, Corinna Engel, et al.. (2009). NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide. Journal of Clinical Oncology. 27(35). 5874–5880. 571 indexed citations breakdown →
9.
Oldenburg, Olaf, et al.. (2008). Das Shy-Drager-Syndrom: Seltene Ursache einer orthostatischen Hypotonie. DMW - Deutsche Medizinische Wochenschrift. 124(01/02). 8–12.
10.
Saner, Fuat H., Yanli Gu, Nils R. Frühauf, et al.. (2006). Neurological complications after cadaveric and living donor liver transplantation. Journal of Neurology. 253(5). 612–617. 58 indexed citations
11.
Koeppen, Susanne, Klaus Kraywinkel, Thomas Wessendorf, et al.. (2006). Long-term outcome of Guillain-Barré syndrome. Neurocritical Care. 5(3). 235–242. 30 indexed citations
12.
Verstappen, C.C.P., Susanne Koeppen, J.J. Heimans, et al.. (2005). Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology. 64(6). 1076–1077. 136 indexed citations
13.
Koeppen, Susanne, C.C.P. Verstappen, M. E. Scheulen, et al.. (2004). Lack of neuroprotection by an ACTH (4?9) analogue. A randomized trial in patients treated with vincristine for Hodgkin?s or non-Hodgkin?s lymphoma. Journal of Cancer Research and Clinical Oncology. 130(3). 153–160. 26 indexed citations
14.
Strumberg, Dirk, Simone van der Sar–van der Brugge, Susanne Koeppen, et al.. (2002). Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Annals of Oncology. 13(2). 229–236. 166 indexed citations
15.
Oldenburg, Olaf, Anna Mitchell, Jens Nürnberger, et al.. (2001). Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension. Journal of the American College of Cardiology. 37(1). 219–223. 28 indexed citations
17.
Wiegand, Frank, Susanne Koeppen, Peter Häussermann, & A Delcker. (1999). Neurozystizerkose. Der Nervenarzt. 70(4). 298–305. 9 indexed citations
18.
Kribben, Andreas, et al.. (1998). Ambulatory Infusion of Noradrenaline for Long-Term Treatment of Shy-Drager Syndrome. Kidney & Blood Pressure Research. 21(1). 70–73. 4 indexed citations
19.
Koeppen, Susanne, et al.. (1959). [Kneipp therapy in internal medicine].. PubMed. 30. 884–7. 2 indexed citations
20.
Koeppen, Susanne. (1955). [Neurologic diseases in an etiologic connection with high- and low voltage accidents].. PubMed. 26(8). 354–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026